SCHEMBL23166329

SCHEMBL23166329

CC(C)(C)OC(=O)N1CCC(NCc2cn[nH]c2)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK1 P23458 1/20 0.50
GPR119 Q8TDV5 4/20 0.48
ALDH1A1 P00352 2/20 0.46
EPHX1 P07099 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
MAPT P10636 2/20 0.46
NPC1 O15118 1/20 0.46
MAPK1 P28482 1/20 0.46
HTT P42858 1/20 0.46
RAB9A P51151 1/20 0.46
KDM4E B2RXH2 2/20 0.43
THRB P10828 1/20 0.43
PTPN2 P17706 1/20 0.43
PTPN1 P18031 1/20 0.43
PTPN6 P29350 1/20 0.43
CCNT1 O60563 1/20 0.43
LMNA P02545 1/20 0.43
STS P08842 1/20 0.43
PKM P14618 1/20 0.42
HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17713834 0.82 GPR119 (0.51) JAK1GPR119MAPTKDM4ETHRB
SCHEMBL13398116 0.81 USP30 (0.53) GPR119ALDH1A1EPHX1L3MBTL1MAPT
SCHEMBL616004 0.81 STS (0.60) JAK1GPR119ALDH1A1EPHX1L3MBTL1
SCHEMBL2793493 0.80 GPR119 (0.57) GPR119ALDH1A1EPHX1L3MBTL1MAPT
SCHEMBL16466490 0.80 USP30 (0.48) GPR119ALDH1A1EPHX1L3MBTL1MAPT
SCHEMBL13398040 0.80 NAMPT (0.60) GPR119ALDH1A1EPHX1L3MBTL1MAPT
SCHEMBL15205875 0.79 IDO1 (0.44) GPR119ALDH1A1EPHX1L3MBTL1MAPT
SCHEMBL3984822 0.79 ALDH1A1 (0.48) GPR119ALDH1A1EPHX1L3MBTL1MAPT
SCHEMBL5013239 0.79 ALDH1A1 (0.51) GPR119ALDH1A1EPHX1L3MBTL1MAPT
SCHEMBL4139902 0.79 DNMT3A (0.56) GPR119ALDH1A1EPHX1L3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220389009-A1 SUBSTITUTED 1,6-NAPHTHYRIDINE INHIBITORS OF CDK5 GFB (ABC), LLC 2022-12-08 US disclosed
EP-4037683-A1 SUBSTITUTED 1, 6-NAPHTHYRIDINE INHIBITORS OF CDK5 Goldfinch Bio, Inc. (US) 2022-08-10 EP disclosed
CN-114761000-A Substituted 1, 6-naphthyridine inhibitors of CDK5 金翅雀生物公司 2022-07-15 CN disclosed
WO-2021067569-A1 SUBSTITUTED 1, 6-NAPHTHYRIDINE INHIBITORS OF CDK5 GOLDFINCH BIO, INC. (US) 2021-04-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220389009-A1 SUBSTITUTED 1,6-NAPHTHYRIDINE INHIBITORS OF CDK5 CDK5, CDK5R1, PKD1 JAK1 980/4885GPR119 2121/4885ALDH1A1 2375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.